Serum bone gla-protein in osteoporosis treated with 1α-hydroxyvitamin D3 for more than five years

[1]  C. Christiansen,et al.  Serum bone Gla protein and other biochemical estimates of bone turnover in early postmenopausal women during prophylactic treatment for osteoporosis. , 2009, Acta medica Scandinavica.

[2]  正昭 荒川,et al.  血液透析患者の血清bone Gla-protein , 1988 .

[3]  A. Zinsmeister,et al.  1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women. , 1987, The Journal of clinical investigation.

[4]  J. Aloia,et al.  Serum osteocalcin and total body calcium in normal pre- and postmenopausal women and postmenopausal osteoporotic patients. , 1987, The Journal of clinical endocrinology and metabolism.

[5]  I. Reid,et al.  Calcium supplements in the prevention of steroid-induced osteoporosis. , 1986, The American journal of clinical nutrition.

[6]  F. Ismail.  Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis , 1986, Calcified Tissue International.

[7]  R. Nuti,et al.  Effect of a long-term treatment with 1,25-dihydroxyvitamin D3 on osteocalcin in postmenopausal osteoporosis , 1986, Calcified Tissue International.

[8]  J. Zerwekh,et al.  Short-term 1,25-dihydroxyvitamin D3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis. , 1985, The Journal of clinical endocrinology and metabolism.

[9]  H. Malluche,et al.  Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis. , 1984, Kidney international.

[10]  H. Orimo,et al.  [Osteocalcin level in the plasma of normal subjects and patients with metabolic bone disease--correlation between various serum parameters]. , 1984, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[11]  J. Lian,et al.  Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. , 1984, The Journal of clinical endocrinology and metabolism.

[12]  P. Delmas,et al.  SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSIS , 1984, The Lancet.

[13]  S. Epstein,et al.  DIFFERENCES IN SERUM BONE GLA PROTEIN WITH AGE AND SEX , 1984, The Lancet.

[14]  K. Mann,et al.  Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. , 1983, The Journal of laboratory and clinical medicine.

[15]  J. Lian,et al.  Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3. , 1983, The Journal of clinical endocrinology and metabolism.

[16]  P. Price,et al.  1,25-dihydroxyvitamin D3 increases serum levels of the vitamin K-dependent bone protein. , 1981, Biochemical and biophysical research communications.

[17]  L. Deftos,et al.  New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. , 1980, The Journal of clinical investigation.

[18]  J. Winberg,et al.  Does breast milk protect against septicaemia in the newborn? , 1971, Lancet.

[19]  M. García-Carrasco,et al.  Osteocalcin and bone morphometric parameters in adults without bone disease , 2007, Calcified Tissue International.